Sitemap

Galenika donates Hydroxychloroquine Sulfate worth 400,000 Euro in fight against COVID-19

CorD Recommends

Regional Creative Network Established in Belgrade

In an initiative led by the National...

Chile to Install World’s Largest Astronomy Camera 

Chile is set to install the world's...

Lidija Tomić Named “Engineer of the Year” in Serbia for 2024

Dr. Lidija Tomić, an air traffic engineer...

Serbian Buyers Emerge as Major Players in Croatian Property Market

Historically, Slovenians have been the principal property buyers in Croatia, consistently leading in acquisitions with 3,403 properties bought last...

Oxford University to Return Stolen 500-Year-Old Hindu Saint Statue to India

Oxford University in the UK has committed to returning a centuries-old stolen Hindu saint's bronze statue to India, marking...

The Foreign Investors Council and EBRD Hosted Conference On Financial Services

The Foreign Investors Council of Serbia, in cooperation with the European Bank for Reconstruction and Development (EBRD), organised the...

Belgrade Prepares for Expo 2027 with a Focus on Play and Creativity

Belgrade is gearing up to host the Specialized Expo 2027, a global event set to captivate the world from...

European Centrist Parties Retain Majority in New EU Parliament Session

According to preliminary results from the European Parliament elections, the European People's Party (EPP), Social Democrats (S&D), and Liberals...

Galenika a.d. Belgrade produced and placed 372,000 tablets of the medicine Hydroxychloroquine Sulfate on the disposal of the Government of Serbia

The value of the manufactured medicines, which Galenika will donate to the health system of Serbia, is 400,000 euros. Hydroxychloroquine production is completed today and complete quantities will be handed over to the Republic Health Insurance Fund in the coming days.

The technology used in the production of Hydroxychloroquine was provided by an EMS company from Brazil which is the owner of Galenika a.d. Belgrade since November 2017. Our colleagues from the parent company confirmed the adequacy of technological conditions, expertise and ability of Galenika employees to produce this, in the world during the pandemic of COVID-19, a highly sought after medicine by EMS technology. EMS, as its contribution to the fight the Republic of Serbia and its citizens are fighting against the pandemic, has donated complete technology for the production of the drug to Galenika. In this way, Galenika was able to produce the quantities that we donate today to the citizens of Serbia, but it has also permanently acquired the production capacity to assist in its own production in cases of threatened regular supply or emergency needs of our health system.

“We share the concerns of the citizens of the Republic of Serbia in this difficult time. We are working hard to ensure continuity of supply and to provide security for patients and consumers by providing sufficient quantities of our products. Hydroxychloroquine production and donation is our contribution to the common struggle of Serbian citizens and an expression of our desire to support the efforts of the Serbian health system as a socially responsible company. Personally, I am glad that our parent company EMS from Brazil recognized the need and supported our local team in Serbia and our desire to help Serbia. We are all extremely proud of our Galenika employees who have worked hard and with great dedication and Easter to produce Hydroxychloroquine, ” said Ricardo Vian Marques, General Manager of Galenika a.d Belgrade.

Last month, EMS from Brazil, initiated the initiation of clinical trials of Hydroxychloroquine in the treatment of COVID 19, which has so far proven effective in therapeutic combination with other drugs. As a result, Galenika immediately offered her knowledge and resources to actively support the national fight against COVID-19 in Serbia. EMS is manufactured in Brazil and is primarily intended to treat lupus, malaria and rheumatoid arthritis. The drug is introduced into therapy solely based on the opinion of the physician and their instructions on how to use this therapy.

Related Articles

Galenika Strengthens Market Position with New Strategic Partnerships

Galenika has significantly expanded its presence in the pharmaceutical sector by securing an exclusive distribution agreement with Cantabria Labs, a leading Spanish dermatological brand....

Ricardo Vian Marques, General Manager, Galenika

Focus On Quality And Growth Drivers

Despite the challenges of global circumstances in 2023, Galenika successfully ensured the production and distribution of its products to all markets where it operates....

Galenika-Fitofarmacija

Pillar Of Support To Domestic And European Farmers

With 16 registered products that are harmonised with European legislations, phytopharmaceuticals company Galenika-Fitofarmacija a.d. (JSC) is present on 28 markets, 19 of which are...

Carlos Puglia, Galenika Executive Director For Sales And Marketing

We Are Ready For Global Goals

As part of Grupo NC, one of the largest conglomerates in Brazil, Galenika is a company that operates on the global market. Its focus...

EU To Extend Digital Covid Certificate For Travel Until June 2023

As the current EU Digital Covid Certificate rules are set to expire on 30 June, the Committee on Civil Liberties, Justice and Home Affairs...

WHO: Three Possible Scenarios For The Pandemic

The World Health Organization (WHO) has released an updated plan for Covid-19, describing three possible scenarios for how the pandemic may develop by the...

Anti-Vaccine Activists March In D.C. – City That Mandates Coronavirus Vaccination – To Protest Mandates

Thousands of protesters from across the country — including some of the biggest names in the anti-vaccination movement — descended on the nation’s capital Sunday for...

US Supreme Court Blocks Biden’s Workplace Vaccine Mandate

The US Supreme Court has blocked President Joe Biden's rule requiring workers at large companies to be vaccinated or masked and tested weekly. The justices...